ADJUVANTED INFLUENZA VACCINES: DATA FROM DIRECT COMPARATIVE STUDIES
Vaccines are the cornerstone of influenza control, however available vaccines are subject to certain limitations. Adjuvanted vaccines are a promising approach, however available adjuvants have a suboptimal effectiveness and safety profile. Data from direct comparative trials are necessary for select...
Main Authors: | M. I Chernikova, Yu. M Vasiliev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Central Research Institute for Epidemiology
2015-10-01
|
Series: | Журнал микробиологии, эпидемиологии и иммунобиологии |
Subjects: | |
Online Access: | https://microbiol.crie.ru/jour/article/view/14149 |
Similar Items
-
COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES
by: M. I Chernikova, et al.
Published: (2015-12-01) -
Comparative Immunogenicity Evaluation of Characterized Chitosan-Based and Other Adjuvants for Inactivated Influenza Vaccines
by: L. M. Khantimirova, et al.
Published: (2016-02-01) -
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age
by: Joanne Langley, et al.
Published: (2020-07-01) -
Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
by: Kenneth E. Schmader, et al.
Published: (2023-07-01) -
MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico
by: Aurelio Cruz-Valdez, et al.
Published: (2018-02-01)